Review article: helminths as therapeutic agents for inflammatory bowel disease

被引:46
作者
Hunter, MM [1 ]
Mckay, DM [1 ]
机构
[1] McMaster Univ, Intestinal Dis Res Programme, Hamilton, ON L8N 3Z5, Canada
关键词
D O I
10.1111/j.0269-2813.2004.01803.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Over the last decade major advances have been made in our understanding of the mechanisms and mediators of inflammation that hold the promise of the development of new therapies for inflammatory disease. While much is to be gleaned from the application of new technologies, assessment of the age-old host-parasite relationship may also provide insights on how to counter pathological inflammatory events. In the case of inflammatory bowel disease [particularly Crohn's disease, which is associated with T helper 1 (Th1) events] it is proposed that infection with parasitic helminths would be beneficial: the paradigm being that of immune deviation, where Th2 cytokines mobilized in response to the helminth will prevent or antagonize the disease-promoting Th1 events in the gut. The situation is unlikely to be this simple. Here we review and critique the data in support of helminth therapy for inflammatory bowel disease, drawing attention to the gaps in knowledge and presenting a view on how the field may be advanced. While the concept of helminth therapy may be superficially unappealing, this review may convince the reader of the value of more extensive analyses of the impact of helminth infection on enteric inflammation.
引用
收藏
页码:167 / 177
页数:11
相关论文
共 77 条
[1]   Modulating the modulators: Parasites, neuromodulators and host behavioral change [J].
Adamo, SA .
BRAIN BEHAVIOR AND EVOLUTION, 2002, 60 (06) :370-377
[2]  
Ader R, 2003, BRAIN BEHAV IMMUN, V17, pS51
[3]   Ascaris nematodes from pig and human make three antibacterial peptides:: isolation of cecropin P1 and two ASABF peptides [J].
Andersson, M ;
Boman, A ;
Boman, HG .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (03) :599-606
[4]   Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice [J].
Barbara, G ;
Vallance, BA ;
Collins, SM .
GASTROENTEROLOGY, 1997, 113 (04) :1224-1232
[5]   Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy [J].
Borkow, G ;
Leng, QB ;
Weisman, Z ;
Stein, M ;
Galai, N ;
Kalinkovich, A ;
Bentwich, Z .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (08) :1053-1060
[6]   The immunological and genetic basis of inflammatory bowel disease [J].
Bouma, G ;
Strober, W .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (07) :521-533
[7]   Immunohistochemical study of intestinal eosinophils in inflammatory bowel disease [J].
Carvalho, ATP ;
Elia, CCS ;
de Souza, HSP ;
Elias, PRP ;
Pontes, EL ;
Lukashok, HP ;
de Freitas, FCD ;
Silva, JRLE .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 36 (02) :120-125
[8]   Phenotype and cytokine profile of Schistosoma mansoni specific T cell lines and clones derived from schistosomiasis patients with distinct clinical forms [J].
Contigli, C ;
Silva-Teixeira, DN ;
Del Prete, G ;
D'Elios, MM ;
De Carli, M ;
Manghetti, M ;
Amedei, A ;
Almerigogna, F ;
Lambertucci, JR ;
Goes, AM .
CLINICAL IMMUNOLOGY, 1999, 91 (03) :338-344
[9]   Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice [J].
Cooke, A ;
Tonks, P ;
Jones, FM ;
O'Shea, H ;
Hutchings, P ;
Fulford, AJC ;
Dunne, DW .
PARASITE IMMUNOLOGY, 1999, 21 (04) :169-176
[10]   Relationship of extraintestinal involvements in inflammatory bowel disease - New insights into autoimmune pathogenesis [J].
Das, KM .
DIGESTIVE DISEASES AND SCIENCES, 1999, 44 (01) :1-13